JP2024535134A5 - - Google Patents
Info
- Publication number
- JP2024535134A5 JP2024535134A5 JP2024542230A JP2024542230A JP2024535134A5 JP 2024535134 A5 JP2024535134 A5 JP 2024535134A5 JP 2024542230 A JP2024542230 A JP 2024542230A JP 2024542230 A JP2024542230 A JP 2024542230A JP 2024535134 A5 JP2024535134 A5 JP 2024535134A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- pharmaceutically acceptable
- acceptable salt
- compound
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163249110P | 2021-09-28 | 2021-09-28 | |
| US63/249,110 | 2021-09-28 | ||
| CN202111140592 | 2021-09-28 | ||
| CN202111140592.3 | 2021-09-28 | ||
| PCT/CN2022/121554 WO2023051490A1 (zh) | 2021-09-28 | 2022-09-27 | Glp-1受体激动剂固体组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535134A JP2024535134A (ja) | 2024-09-26 |
| JP2024535134A5 true JP2024535134A5 (cg-RX-API-DMAC7.html) | 2025-10-06 |
Family
ID=85780433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024542230A Pending JP2024535134A (ja) | 2021-09-28 | 2022-09-27 | Ｇｌｐ－１受容体アゴニストの固形組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250332157A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4410793A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024535134A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3233453A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023051490A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4777197A2 (en) | 2023-09-14 | 2026-07-22 | Ascletis Pharma (China) Co., Limited | Glp-1r agonist and therapeutic method thereof |
| WO2025109387A1 (en) | 2023-11-24 | 2025-05-30 | Ascletis Pharma (China) Co., Limited | Glp-1r agonist and therapeutic method thereof |
| WO2025158275A1 (en) | 2024-01-24 | 2025-07-31 | Pfizer Inc. | Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds |
| TW202600132A (zh) | 2024-03-08 | 2026-01-01 | 美商安尼波那生物公司 | 用於治療肥胖症及提高減重之方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2011010347A (es) * | 2009-03-30 | 2011-11-29 | Transtech Pharma Inc | Derivados sustituidos de azoantraceno, composiciones farmaceuticas y metodos de uso de los mismos. |
-
2022
- 2022-09-27 US US18/691,835 patent/US20250332157A1/en active Pending
- 2022-09-27 EP EP22874875.2A patent/EP4410793A4/en active Pending
- 2022-09-27 CA CA3233453A patent/CA3233453A1/en active Pending
- 2022-09-27 JP JP2024542230A patent/JP2024535134A/ja active Pending
- 2022-09-27 WO PCT/CN2022/121554 patent/WO2023051490A1/zh not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5658172B2 (ja) | アムロジピン及びロサルタンを含む固形薬剤学的組成物及びその製造方法 | |
| DK2295035T3 (en) | Double acting pharmaceutical compositions based on superstructures of angiotensin receptor antagonists / blockers (arb) and neutral endopeptidase (nep) inhibitors | |
| CN1164389A (zh) | 缓释制剂 | |
| JP2003517446A (ja) | 新規制御放出ビーズ、その製造方法、およびそれを含む多重ユニット製剤 | |
| CN115315426A (zh) | Glp-1受体激动剂游离碱的药学上可接受的酸式盐及其制备方法 | |
| FR2783421A1 (fr) | Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications | |
| JP7787088B2 (ja) | シタグリプチン、ダパグリフロジン及びメトホルミンを含む経口用複合錠剤 | |
| CN105792813A (zh) | 一种含有氨氯地平、氯沙坦和罗苏伐他汀的药物组合制剂 | |
| CN112641742B (zh) | 一种沙库巴曲缬沙坦钠缓释片及其制备方法 | |
| KR102687535B1 (ko) | 무정형의 다파글리플로진 l-프롤린을 포함하는 약학적 제제 및 이의 제조방법 | |
| UA122224C2 (uk) | Комбінована композиція тезофензину і бета-блокатора | |
| TW201628602A (zh) | 糖尿病治療用藥劑學組合物及其製備方法 | |
| KR20140002812A (ko) | 알레글리타자르를 포함하는 약학 조성물 | |
| CN116115579B (zh) | 一种洛索洛芬钠的控释片、制备方法及应用 | |
| CN102258496B (zh) | 溴吡斯的明缓释片剂及其制备方法 | |
| JP2002512263A (ja) | Ｓ−レイブプラゾール組成物及び方法 | |
| TWI699201B (zh) | 用於預防及治療糖尿病之經取代之芳族化合物及醫藥組合物 | |
| CN101766582A (zh) | 一种苯磺酸左旋氨氯地平的片剂及其制备方法 | |
| JP2024524113A (ja) | シタグリプチン、ダパグリフロジン及びメトホルミンを含む経口用複合錠剤 | |
| JPH08509738A (ja) | 光学的に純粋な（＋）パントプラゾールを用いる胃の疾患治療の方法と組成 | |
| KR101128891B1 (ko) | 로라타딘 및 슈도에페드린을 함유하는 제어 방출 다층정 | |
| CN120022270A (zh) | 一种吲哚布芬缓释制剂及其制备方法和应用 | |
| WO2003082261A1 (en) | Extended release venlafaxine formulations | |
| CN118680891A (zh) | 一种用于治疗心绞痛的制剂组合物及其制备方法 | |
| EP3212185A1 (en) | Pharmaceutical combinations of vildagliptin and ppar agonists |